1. High glucose contributes to the proliferation and migration of non-small-cell lung cancer cells via GAS5-TRIB3 axis
    Cheng-Zhi Ding et al, 2018, Biosci. Rep. CrossRef
  2. Bruceine D induces apoptosis in human non-small cell lung cancer cells through regulating JNK pathway
    Biqin Tan et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  3. Novel role of sex-determining region Y-box 7 (SOX7) in tumor biology and cardiovascular developmental biology
    Wei Hu et al, 2019, Seminars in Cancer Biology CrossRef
  4. The interaction between self – assembling peptides and emodin and the controlled release of emodin from in-situ hydrogel
    Weipeng Wei et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  5. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
  6. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
    Amit S. Choudhari et al, 2020, Front. Pharmacol. CrossRef
  7. The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer
    Anna López‐Plana et al, 2020, Int. J. Cancer CrossRef
  8. Distinct host-immune response toward species related intracellular mycobacterial killing: A transcriptomic study
    Abhilasha Madhvi et al, 2020, Virulence CrossRef
  9. Quinonoids: Therapeutic Potential for Lung Cancer Treatment
    Hua-Zhong Ying et al, 2020, BioMed Research International CrossRef
  10. The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin
    Ya CUI et al, 2020, Chinese Journal of Natural Medicines CrossRef
  11. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
    Jiao-jiao Yu et al, 2020, Nat Commun CrossRef

  12. Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway


    Hongfei Tong et al, 2020, OTT CrossRef
  13. Uncovering the Anti-Lung-Cancer Mechanisms of the Herbal Drug FDY2004 by Network Pharmacology
    Ho-Sung Lee et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  14. Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy
    The Hong Phong Nguyen et al, 2021, Process Biochemistry CrossRef
  15. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.
    Tingting Wen et al, 2021, Cancer Med CrossRef
  16. A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets
    Hardeep Singh Tuli et al, 2021, Toxicology in Vitro CrossRef
  17. Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of Emodin in vitro and in vivo
    Hui Liu et al, 2021, Journal of Pharmaceutical Sciences CrossRef
  18. Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin
    Esra Küpeli Akkol et al, 2021, Cancers CrossRef
  19. EFFECTS OF PHOTODYNAMIC THERAPY MEDIATED BY EMODIN IN CERVICAL CARCINOMA CELLS
    Ana Emília Brumatti Galiardi-Campoy et al, 2021, Photodiagnosis and Photodynamic Therapy CrossRef
  20. Emodin - A natural anthraquinone derivative with diverse pharmacological activities
    Ruchi Badoni Semwal et al, 2021, Phytochemistry CrossRef
  21. Exploring the Potential of Medicinal Plants in Lung Cancer
    Anju Dhiman et al, 2021 CrossRef
  22. Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis
    Li Yi et al, 2021, BMC Pulm Med CrossRef
  23. Emodin relieves hypoxia-triggered injury via elevation of microRNA-25 in PC-12 cells
    Mingjuan Cao et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  24. Natural anthraquinone compound emodin as a novel inhibitor of aurora A kinase: A pilot study
    Fen‐Lan Wu et al, 2021, Chem Biol Drug Des CrossRef
  25. Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK
    Weilong Li et al, 2021, Exp Ther Med CrossRef
  26. Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa
    Fang-Yuan Zhang et al, 2021, Phytomedicine CrossRef
  27. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
    Qi Zheng et al, 2021, Chin Med CrossRef
  28. The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer
    Alba Orea-Soufi et al, 2021, Cancers CrossRef
  29. Emodin alleviates acute hypoxia-induced apoptosis in gibel carp (Carassius gibelio) by upregulating autophagy through modulation of the AMPK/mTOR pathway
    Liyun Wu et al, 2021, Aquaculture CrossRef
  30. Emodin Induces Apoptosis of Colon Cancer Cells via Induction of Autophagy in a ROS-Dependent Manner.
    Yuanyuan Wang et al, 0 CrossRef
  31. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells
    null So Young Kim et al, 2022, Chemico-Biological Interactions CrossRef
  32. The expression profile of lung long non-coding RNAs and mRNAs in a mouse model of smoke inhalation injury
    Zheng-Ying Jiang et al, 2022, Bioengineered CrossRef
  33. Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-Based Systems for Effective Management of Lung Cancer
    Mahak Fatima et al, 2022, ACAMC CrossRef
  34. LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p.
    Jun Bai et al, 2022, Front Oncol CrossRef
  35. Recent advances in the therapeutic potential of emodin for human health
    Javad Sharifi-Rad et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  36. Local anesthetic lidocaine-inducible gene, growth differentiation factor-15 suppresses the growth of cancer cell lines
    Keiko Haraguchi-Suzuki et al, 2022, Sci Rep CrossRef
  37. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis
    Qian-zhi Chen et al, 2022, CURR MED SCI CrossRef
  38. Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review
    Subham Das et al, 2022, CMC CrossRef
  39. Promising Role of Phytochemicals in the Prevention and Treatment of Cancer
    Aziz Unnisa et al, 2022, ACAMC CrossRef
  40. The Regulatory Network of Gastric Cancer Pathogenesis and Its Potential Therapeutic Active Ingredients of Traditional Chinese Medicine Based on Bioinformatics, Molecular Docking, and Molecular Dynamics Simulation
    Peng Yang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  41. The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer
    Anam Arif et al, 2023, International Immunopharmacology CrossRef
  42. Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
    Xiuli Yang et al, 2023, Heliyon CrossRef
  43. Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
    Yongxia Zhao et al, 2023, Metabolites CrossRef
  44. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds
    Neeraj Choudhary et al, 2023, Cancers CrossRef
  45. Bioactive Compounds and Biological Activities of Tuber Fleeceflower Root (Polygonum multiflorum Thunb.)
    Thanh-Tam Ho et al, 2023 CrossRef
  46. Emodin suppresses adipogenesis of bone marrow derived mesenchymal stem cells from aplastic anemia via increasing TRIB3 expression
    Xianning Zhang et al, 2023, Tissue and Cell CrossRef
  47. The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy
    Chung-Chun Wu et al, 2024, Biomedicines CrossRef
  48. Natural products targeting autophagy and apoptosis in NSCLC: a novel therapeutic strategy
    Peiyi Qin et al, 2024, Front. Oncol. CrossRef
  49. New insights into the interaction of emodin with lipid membranes
    Antonio R. da Cunha et al, 2024, Biophysical Chemistry CrossRef
  50. Bioactive Compounds and Biological Activities of Tuber Fleeceflower Root (Polygonum multiflorum Thunb.)
    Thanh-Tam Ho et al, 2024 CrossRef
  51. Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent‐loaded nanoparticles
    Taufique Siddiquee et al, 2024, Phytotherapy Research CrossRef
  52. Comprehensive identification strategy for rapid profiling of chemical constituents using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry with Rhubarb as an example
    Min Yao et al, 2024, Journal of Chromatography A CrossRef
  53. Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways.
    Ivones Hernández-Balmaseda et al, 2021, Mar Drugs CrossRef
  54. Diverse functions of Tribbles homolog 3 in cancers and its potential as a therapeutic target
    Shiying Lei et al, 2024 CrossRef
  55. Isobavachalcone: A redox antifungal agent impairs the mitochondria protein of Cryptococcus neoformans
    Xue Wang et al, 2024, International Journal of Antimicrobial Agents CrossRef
  56. Liraglutide ameliorates high glucose-induced vascular endothelial injury through TRIB3/NF-κB signaling pathway
    Lili Shi et al, 2024, In Vitro Cell.Dev.Biol.-Animal CrossRef
  57. Natural Products and Altered Metabolism in Cancer: Therapeutic Targets and Mechanisms of Action
    Wamidh H. Talib et al, 2024, IJMS CrossRef
  58. Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer
    Adam Haysom‐McDowell et al, 2024, Molecular Oncology CrossRef
  59. Emodin regulated lactate metabolism by inhibiting MCT1 to delay non-small cell lung cancer progression
    Fei Zhang et al, 2024, Human Cell CrossRef